XML 21 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities    
Net loss $ (590,451) $ (3,500,371)
Adjustments to reconcile net loss to cash flows from operating activities    
Depletion, depreciation, and amortization 198,919 419,304
Write-down of oil and natural gas properties 810,921 3,612,600
Impairment of goodwill 0 1,261,512
Deferred income taxes (331,574) (1,432,572)
Stock-based compensation 9,682 22,637
Commodity derivatives expense (income) 99,811 (126,178)
Receipt on settlements of commodity derivatives 116,958 433,293
Gain on debt extinguishment (115,095) 0
Debt issuance costs and discounts 15,541 6,810
Other, net (3,271) (7,457)
Changes in assets and liabilities, net of effects from acquisitions    
Accrued production receivable (2,207) 57,867
Trade and other receivables 35,911 37,463
Other current and long-term assets (8,434) (1,771)
Accounts payable and accrued liabilities (57,830) (53,124)
Oil and natural gas production payable (13,290) (26,478)
Other liabilities (6,232) (4,138)
Net cash provided by operating activities 159,359 699,397
Cash flows from investing activities    
Oil and natural gas capital expenditures (176,631) (364,948)
Acquisitions of oil and natural gas properties (560) (21,171)
CO2 capital expenditures (467) (21,894)
Pipelines and plants capital expenditures (2,881) (25,767)
Net proceeds from sales of oil and natural gas properties and equipment 47,232 327
Other (700) 5,913
Net cash used in investing activities (134,007) (427,540)
Cash flows from financing activities    
Bank repayments (1,362,500) (1,491,000)
Bank borrowings 1,447,500 1,306,000
Repurchases of senior subordinated notes (76,708) 0
Pipeline financing and capital lease debt repayments (21,510) (25,638)
Cash dividends paid (478) (65,422)
Other (11,195) (6,738)
Net cash provided by (used in) financing activities (24,891) (282,798)
Net increase (decrease) in cash and cash equivalents 461 (10,941)
Cash and cash equivalents at beginning of period 2,812 23,153
Cash and cash equivalents at end of period $ 3,273 $ 12,212